Literature DB >> 10413699

Prophylactic scleral buckle for prevention of retinal detachment following vitrectomy for macular hole.

T S Chang1, E McGill, D A Hay, W H Ross, A L Maberley, L M Sibley, P E Ma, M J Potter.   

Abstract

AIM: To review the rate of retinal detachment after macular hole surgery in patients who received vitrectomy and scleral buckle versus those who had vitrectomy alone.
METHODS: All patient charts and hospital records were examined for patients who underwent vitrectomy surgery for macular hole between September 1993 and June 1997. A total of 326 patients were identified and all were followed for a minimum of 6 months. Clinical records were examined for details of the surgical procedure, visual acuity, hole closure status, adjuvant therapies used, and postoperative retinal attachment status. Relative risks (the ratio of the incidence rate in the exposed to that in the unexposed) with 95% confidence intervals and chi(2) tests were calculated to determine which variables were associated with retinal detachment. The primary outcome measure in this review was retinal attachment status.
RESULTS: Of 326 eyes which underwent surgery for macular hole during the study period, scleral buckles were utilised in 152 (46.6%) patients. Analysis revealed a detachment rate of 13.2% in patients who did not receive a scleral buckle compared with 5.9% detachment rate in those who did. Analysis of these results indicated a 2.42 times greater risk of developing a retinal detachment in patients without a scleral buckle. Complications related to the use of scleral buckles occurred in two of 152 cases (1.3%)
CONCLUSIONS: A reduction in the rate of retinal detachment was noted in patients receiving prophylactic scleral buckles. Those finding suggest a possible beneficial effect of this adjunctive procedure in preventing postoperative retinal detachments. The authors are currently preparing a multicentred, prospective, clinical trial to further study this hypothesis

Entities:  

Mesh:

Year:  1999        PMID: 10413699      PMCID: PMC1723162          DOI: 10.1136/bjo.83.8.944

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  18 in total

1.  Pars plana vitrectomy. The role of vitrectomy in penetrating ocular injuries.

Authors:  W L Hutton
Journal:  Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol       Date:  1976 May-Jun

2.  Spontaneous resolution of retinal detachment occurring after macular hole surgery.

Authors:  L Akduman; L V Del Priore; H J Kaplan
Journal:  Arch Ophthalmol       Date:  1998-04

3.  Idiopathic senile macular hole. Its early stages and pathogenesis.

Authors:  J D Gass
Journal:  Arch Ophthalmol       Date:  1988-05

4.  Vitrectomy for impending idiopathic macular holes.

Authors:  W E Smiddy; R G Michels; B M Glaser; S de Bustros
Journal:  Am J Ophthalmol       Date:  1988-04-15       Impact factor: 5.258

5.  Vision-threatening complications of surgery for full-thickness macular holes. Vitrectomy for Macular Hole Study Group.

Authors:  A S Banker; W R Freeman; J W Kim; D Munguia; S P Azen
Journal:  Ophthalmology       Date:  1997-09       Impact factor: 12.079

6.  Prophylactic scleral buckling in perforating ocular injuries involving the posterior segment.

Authors:  M Rosner; E Bartov; G Treister; M Belkin
Journal:  Ann Ophthalmol       Date:  1988-04

7.  Vitrectomy for the treatment of full-thickness stage 3 or 4 macular holes. Results of a multicentered randomized clinical trial. The Vitrectomy for Treatment of Macular Hole Study Group.

Authors:  W R Freeman; S P Azen; J W Kim; W el-Haig; D R Mishell; I Bailey
Journal:  Arch Ophthalmol       Date:  1997-01

8.  Vitreous surgery for idiopathic macular holes. Results of a pilot study.

Authors:  N E Kelly; R T Wendel
Journal:  Arch Ophthalmol       Date:  1991-05

9.  Corneal endothelial permeability after anterior chamber silicone oil.

Authors:  B C Norman; J Oliver; L Cheeks; D S Hull; D Birnbaum; K Green
Journal:  Ophthalmology       Date:  1990-12       Impact factor: 12.079

10.  Surgical results of vitrectomy in ocular trauma.

Authors:  Y Miyake; F Ando
Journal:  Retina       Date:  1983 Fall-Winter       Impact factor: 4.256

View more
  8 in total

Review 1.  [Vitrectomy with or without cerclage in the treatment of retinal detachment].

Authors:  F Ziemssen; K U Bartz-Schmidt
Journal:  Ophthalmologe       Date:  2004-06       Impact factor: 1.059

2.  [Incidence and prophylaxis of retinal detachment following pars plana vitrectomy].

Authors:  M Rauber; U Mester
Journal:  Ophthalmologe       Date:  2006-08       Impact factor: 1.059

3.  Phacovitrectomy without prone posture for full thickness macular holes.

Authors:  P R Simcock; S Scalia
Journal:  Br J Ophthalmol       Date:  2001-11       Impact factor: 4.638

4.  Prophylactic Laser Treatment Posterior to Pars Plana Vitrectomy Sclerotomy Wounds During Macular Surgery.

Authors:  Radwan S Ajlan; Matthew M Pfannenstiel; Joseph R Luvisi
Journal:  Kans J Med       Date:  2022-06-20

5.  [Vitreoretinal secondary procedures following elective macular surgery].

Authors:  A Hager; S Ehrich; W Wiegand
Journal:  Ophthalmologe       Date:  2004-01       Impact factor: 1.059

6.  Internal limiting membrane removal in macular hole surgery for severely myopic eyes: a case-control study.

Authors:  A K H Kwok; T Y Y Lai
Journal:  Br J Ophthalmol       Date:  2003-07       Impact factor: 4.638

7.  The Incidence of Rhegmatogenous Retinal Complications in Macular Surgery After Prophylactic Preoperative Laser Retinopexy: A Retrospective Study.

Authors:  Gian Marco Tosi; Pierluigi Esposti; Napoleone Romeo; Davide Marigliani; Gabriele Cevenini; Patrizio Massimo; Elisabetta Nuti; Giulia Esposti; Guido Ripandelli
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

8.  Effect of prophylactic 360° laser treatment for prevention of retinal detachment after phacovitrectomy: (Prophylactic 360° laser treatment for prevention of retinal detachment).

Authors:  Takeshi Iwase; Young-Joon Jo; Brian C Oveson
Journal:  BMC Ophthalmol       Date:  2013-12-10       Impact factor: 2.209

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.